Targeting ion transport in cancer

Abstract

The metabolism of cancer cells differs substantially from normal cells, including ion transport. Although this phenomenon has been long recognized, ion transporters have not been viewed as suitable therapeutic targets. However, the acidic pH values present in tumours which are well outside of normal limits are now becoming recognized as an important therapeutic target. Carbonic anhydrase IX (CAIX) is fundamental to tumour pH regulation. CAIX is commonly expressed in cancer, but lowly expressed in normal tissues and that presents an attractive target. Here, we discuss the possibilities of exploiting the acidic, hypoxic tumour environment as possible target for therapy. Additionally, clinical experience with CAIX targeting in cancer patients is discussed.

EpilepsyGene: a genetic resource for genes and mutations related to epilepsy

“…By contrast, the ‘blue’ and ‘gray’ genes were enriched in channel activities, and both sets represent similar expression pattern in brain after 18 months after birth. In addition, the ‘green’ genes displayed statistically significant enrichment in ‘ion transport’ (Figure 2C ), a major role in ion channels ( 40 ), which are of crucial importance in various processes, such as nerve excitation, cell proliferation, sensory transduction, and learning and memory ( 41 , 42 ). This may explain why the corresponding expression pattern (Figure 2A ) suggests an increase since 8–9 post-conception weeks.…”

Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?

“…Targeting transporters and channels in cancer is presently envisioned as novel and very promising area of anticancer therapy ( Arcangeli et al, 2009 ; Oosterwijk and Gillies, 2014 ). A successful use of drugs targeting ion channels for treatment of multiple diseases unrelated to cancer indicates that these drugs can be well tolerated and safely used over a long time period.…”

OEsophageal Ion Transport Mechanisms and Significance Under Pathological Conditions

“…Therefore, there is an urgent need to develop new therapies that can complement existing treatments or allow individual therapies. Disturbances of ion transport processes are considered to be of great importance in cancer research (Pedersen and Stock, 2013;Djamgoz et al, 2014;Oosterwijk and Gillies, 2014;Stock and Schwab, 2015;Martial, 2016). Ion transporters are not only involved in tumorigenesis by altering the membrane permeability of certain ions, but some transporters interact with other signaling molecules (kinases, transcription factors) that influence the cell cycle or the metastatic potential of the cells.…”